SPOTLIGHT -
FDA approves first long-term implantable glucose-monitoring system
Avastin gains approval for another cancer type
The manufacturer of bevacizumab (Avastin), snagged FDA approval for yet another type of cancer.
Manufacturer blocks sale of generic Suboxone
FDA backs new biosimilar, plus 2 more approvals
FDA approved the first biosimilar to Neulasta, as well as a new combination treatment for osteoarthritis pain and hypertension and a new drug to treat chronic lymphocytic leukemia.
Cancer drug prices rise despite Trump plan
The manufacturer of two cancer drugs hiked the price on the medicines despite President Donald Trump’s new plan to lower drug prices.
FDA: Deaths linked to obesity devices
FDA is warning that 2 liquid-filled intragastric balloon systems used to treat obesity are causing deaths in some patients
How FDA is accelerating generics, biosimilars to market
FDA’s new guidances on Risk Evaluation and Mitigation Strategy (REMS) requirements aims to help generic and biosimilar drugs get to market faster.
FDA wants certain OTC teething gels off the market
FDA is asking manufacturers to immediately stop selling OTC products containing the pain reliever benzocaine (such as Orajel) for teething in infants or children.
Top 3 drug alerts of 2018
While the pharmaceutical industry has made tremendous advances in new drug development this year, FDA has also had to remove drugs from the market or investigate problem drugs. Here are the top 3 drug warnings and problems so far in 2018.
FDA approves first factor Xa inhibitor antidote
Top 3 new drug approvals
Breakthrough childhood MS drug okayed
Pharmacy chains praise Trump drug pricing plan
First smallpox treatment on the horizon
The first smallpox treatment, being developed for the United States government in the case of a bioterrorism attack, could be available as early as August.
FDA approves first combo treatment for BRAF-positive anaplastic thyroid cancer
A combination cancer treatment has been expanded to include treating both melanoma and anaplastic thyroid cancer (ATC).
